Campral overview
Campral is a medicine used to support maintenance of alcohol abstinence in adults with alcohol dependence. Its active ingredient is acamprosate calcium. It is intended to be part of a broader treatment plan that includes counselling, psychosocial support, and follow-up.
Campral does not treat alcohol intoxication or replace urgent care for alcohol withdrawal. It is usually considered after alcohol withdrawal has been medically managed and the person has stopped drinking. A prescriber can determine whether acamprosate is appropriate for an individual situation.
For people seeking treatment options in Sweden, a licensed healthcare professional remains the right source for personalised assessment. Alcohol dependence can involve medical, mental-health, and social factors. Medicines work best when these factors are addressed together.
What Campral is used for
Campral is used to help adults with alcohol dependence maintain abstinence after they have stopped drinking. It may reduce the distressing imbalance in brain signalling that can persist after regular alcohol use ends. This can make continued recovery support more manageable for some people.
The medicine is not designed to create an unpleasant reaction if alcohol is consumed. It is also not a cure for alcohol dependence. Continued drinking, relapse risk, and treatment goals should be discussed openly with a healthcare professional.
Campral is commonly combined with structured support, such as addiction counselling, peer support, or behavioural therapy. These approaches can help identify triggers and develop practical relapse-prevention plans. Regular review allows treatment to be adjusted when needed.
Active ingredient and development
The active ingredient in Campral is acamprosate calcium, also called calcium acetylhomotaurinate. It is supplied as an oral delayed-release tablet in many markets. The formulation is designed to deliver acamprosate after the tablet passes through the stomach.
Acamprosate was developed through research into the changes in brain chemistry associated with long-term alcohol exposure and early abstinence. It became established in European alcohol-dependence treatment before gaining wider international use. Its development reflected the need for non-sedating medication options to accompany psychosocial care.
Research has continued to examine which patients may benefit most and how medicine fits into comprehensive treatment. Results are interpreted alongside a person’s drinking history, kidney function, adherence, and access to support. A pharmacist can explain the product information supplied with a particular pack.
How acamprosate works
Alcohol affects several neurotransmitter systems in the brain, including excitatory and inhibitory signalling. After prolonged alcohol use stops, these systems may remain out of balance for a period of time. Acamprosate is thought to help stabilise this disrupted signalling.
Its exact mechanism is not fully defined, but it is associated with modulation of glutamate-related activity and other neural pathways. It does not act like a sedative and does not produce the immediate calming effect associated with some medicines. The benefit, when it occurs, is generally linked to consistent use alongside abstinence-focused care.
Campral should not be judged after only one dose. Treatment response is usually reviewed over time by the clinician managing alcohol-dependence care. If drinking resumes or symptoms change, the treatment team should be informed promptly.
Available strengths and dosage forms
Campral is commonly available as delayed-release tablets containing 333 mg of acamprosate calcium. Pack sizes and brand availability can differ between suppliers and may change over time. The dispensing pharmacy should provide the exact strength and patient leaflet for the product supplied.
Dosage is individualised and depends on the approved local product information and clinical factors. In some product information, daily dosing is divided into three administrations. Patients should follow the directions on their prescription label rather than relying on a general schedule.
Tablets should be swallowed whole unless the supplied leaflet or pharmacist says otherwise. Crushing or altering delayed-release tablets may affect how they are delivered. If swallowing tablets is difficult, ask a pharmacist or prescriber before making any changes.
How to take Campral safely
Campral is generally started when the person is abstinent from alcohol and has completed appropriate withdrawal management. It may be taken with or without food, depending on the instructions provided for the dispensed product. Taking doses at consistent times can support adherence.
If a dose is missed, patients should consult the product leaflet or a pharmacist for suitable guidance. Taking extra tablets to compensate for a missed dose is not appropriate. An accidental double dose may require advice from a poison information service or healthcare professional.
Do not stop, restart, or change the dose without discussing it with the prescriber. This is especially important if there are new kidney problems, persistent diarrhoea, or a return to alcohol use. Ongoing counselling and medical appointments remain important during treatment.
How long Campral stays in the body
Acamprosate is eliminated mainly through the kidneys and is largely excreted unchanged in urine. Its elimination half-life is generally described as being in the range of roughly 20 to 33 hours. This does not mean the medicine is fully gone after one day, because elimination occurs gradually over several half-lives.
Kidney function can substantially affect how long acamprosate remains in the body. Reduced kidney function may increase exposure and can make treatment unsuitable or require clinical reassessment. A prescriber may use relevant medical history and tests to assess this risk.
The duration in the body should not be used to decide when it is safe to drink alcohol or to self-manage withdrawal. Alcohol-related risks depend on many factors beyond acamprosate levels. Medical advice is particularly important for people with severe dependence or a history of withdrawal complications.
Duration of effect and treatment expectations
Campral does not usually produce a noticeable immediate effect after each tablet. Its intended role is to support abstinence over a sustained treatment period. Consistent dosing is more relevant than expecting a short, on-demand effect.
The length of treatment varies according to individual clinical needs and the local approved information. A clinician may periodically review abstinence goals, adverse effects, kidney health, and engagement with support services. Continuing treatment is a shared clinical decision.
Recovery can include setbacks, and a lapse should not automatically lead to abandoning care. Contacting the prescriber or support team early can help reassess the plan safely. Urgent help is needed if alcohol withdrawal symptoms are severe or if there are thoughts of self-harm.
Scientific evidence for Campral
Clinical research has evaluated acamprosate as an aid to maintaining abstinence in alcohol dependence. Overall evidence supports a benefit for some abstinent patients when the medicine is combined with psychosocial treatment. Individual outcomes vary, and no medicine removes the need for recovery support.
Studies commonly assess outcomes such as time to first drink, cumulative abstinence, and relapse patterns. Differences in study design, patient populations, and accompanying therapy can affect results. For this reason, evidence is best applied through an individual clinical assessment.
Campral has been used for many years, so clinicians have practical experience with its tolerability and limitations. Its kidney-based elimination is a key consideration when selecting treatment. A prescriber can compare its evidence and safety profile with other suitable options.
Dependence, addiction, and misuse potential
Campral is not considered to be addictive and is not known to cause drug-seeking effects. It does not produce intoxication or a rewarding “high.” Physical dependence on acamprosate is not expected when it is used as directed.
However, alcohol dependence itself remains a serious condition requiring continuing support. Stopping Campral does not remove the underlying risk of relapse. Treatment should therefore focus on the person’s broader recovery plan rather than medication alone.
Any medicine should be kept secure and used only by the person for whom it was prescribed. Do not share tablets with another person, even if their symptoms seem similar. A pharmacist can advise on safe disposal of unused or expired tablets.
Side effects and allergic reactions
Commonly reported side effects of acamprosate can include diarrhoea, abdominal discomfort, nausea, headache, dizziness, itching, and skin rash. Side effects may be mild for some people but should still be discussed if persistent or troublesome. Adequate fluid intake may be particularly important if diarrhoea occurs.
Serious allergic reactions are uncommon but require urgent medical attention. Warning signs can include swelling of the face, lips, tongue, or throat, trouble breathing, widespread hives, or a severe blistering rash. Do not take further doses until urgent medical advice has been obtained.
Changes in mood, marked anxiety, depression, or thoughts of self-harm should be treated seriously. These symptoms may relate to alcohol dependence, withdrawal, other health conditions, or treatment circumstances. Seek urgent help through Swedish emergency services if there is immediate danger.
Who should not take Campral
Campral should not be used by anyone with a known allergy to acamprosate or any ingredient in the specific product. Severe kidney impairment is generally a contraindication because acamprosate is cleared through the kidneys. The prescriber must review kidney health before and during treatment where appropriate.
Campral is generally authorised for adults, and use in children or adolescents is not usually recommended because adequate safety and effectiveness data are limited. Older adults may need careful assessment, particularly where kidney function is reduced. Age alone does not replace an individual medical review.
Pregnancy, breast-feeding, liver disease, mental-health conditions, and other medicines should be discussed before treatment starts. Alcohol dependence during pregnancy requires specialist care because both alcohol exposure and withdrawal can carry risks. Never use another person’s prescription as a substitute for assessment.
Alcohol and medicine interactions
Campral is intended to support abstinence, so alcohol use is not compatible with the treatment goal. It is not known for a disulfiram-like reaction with alcohol, but this does not make drinking safe. A return to alcohol can increase relapse and health risks even while taking the medicine.
Before starting Campral, tell the prescriber and pharmacist about all prescription medicines, non-prescription products, supplements, and recreational substances. Acamprosate has relatively limited metabolism-based interactions, but individual circumstances still matter. Kidney function and concurrent illnesses can change the safety assessment.
Alcohol withdrawal can be dangerous for some people, particularly after heavy or prolonged use. Symptoms such as seizures, hallucinations, confusion, severe shaking, or severe vomiting need urgent medical assessment. Campral is not an emergency treatment for these symptoms.
Overdose and urgent action
Taking more Campral than prescribed may increase the likelihood of side effects, particularly gastrointestinal symptoms such as diarrhoea. The exact consequences depend on the amount taken, other substances involved, and the person’s health. Do not wait for symptoms to become severe before seeking advice.
In Sweden, contact the Poisons Information Centre or seek urgent medical care for suspected overdose. Call emergency services immediately if there is loss of consciousness, breathing difficulty, seizures, severe confusion, or a suspected serious allergic reaction. Keep the medicine pack available so professionals can identify the product and strength.
Do not induce vomiting unless a poison specialist or clinician specifically instructs it. Avoid taking further doses until advice has been received. If alcohol, sedatives, or other medicines were also taken, report this clearly to emergency staff.
Storage and handling
Store Campral in its original packaging and follow the temperature and handling instructions on the pack leaflet. Keep it dry and protected from conditions that could damage tablets. Avoid storing medicines in humid places such as bathrooms.
Keep Campral out of the sight and reach of children and pets. A secure cabinet is sensible in households where accidental access is possible. Do not use tablets after the stated expiry date.
Unused medicine should not be disposed of in household wastewater or shared with others. Ask a Swedish pharmacy about appropriate return or disposal options. Correct disposal helps prevent accidental ingestion and environmental contamination.
Campral price and treatment alternatives
Campral price can vary between pharmacies because of pack size, dispensing arrangements, reimbursement eligibility, and supplier availability. Prices shown by other internet pharmacies should be treated as illustrative rather than current guarantees. A licensed pharmacy can confirm the final amount before dispensing.
Alternatives for alcohol dependence may include naltrexone, disulfiram, nalmefene in suitable settings, and non-medicine support programmes. Each option has different goals, contraindications, and monitoring needs. The best choice depends on drinking patterns, physical health, mental health, and the person’s recovery objectives.
Comparing treatments solely by cost can overlook important safety considerations. For example, kidney function may be especially relevant for acamprosate, while other medicines have different restrictions. A prescriber can explain why one option may be preferable in a particular case.
Ordering through our pharmacy
Campral is generally a prescription medicine, and a legitimate pharmacy in Sweden cannot supply it without a valid prescription where one is legally required. Claims of access without prescription should be approached with caution. Prescription verification protects patients from inappropriate treatment and counterfeit medicines.
To place an order through our pharmacy, select the prescribed product and strength, provide the required prescription information, and complete the secure checkout steps. A pharmacist may contact the patient or prescriber if clarification is needed before dispensing. This review is part of safe pharmaceutical care.
After dispatch, package tracking is normally provided through the delivery method selected at checkout. Tracking updates can help the customer follow the parcel while protecting medicine from avoidable delivery delays. Check the parcel and product details on arrival, and contact the pharmacy promptly if anything appears damaged or incorrect.
Frequently asked questions about Campral
Can I buy Campral online in Sweden?
In Sweden, Campral should be supplied only after a valid prescription has been reviewed. A legitimate pharmacy will verify the prescription and provide product information and pharmacist support before dispensing.
Is generic acamprosate the same as Campral?
Generic acamprosate products contain the same active substance as Campral and must meet applicable quality requirements. However, tablet appearance and inactive ingredients can differ, so ask a pharmacist before switching if you have allergies, intolerances, or concerns about a change in product.
Why is kidney function important before starting Campral?
Acamprosate is cleared mainly through the kidneys, so reduced kidney function can affect whether it is appropriate to use. A prescriber may review kidney health before treatment and during follow-up where clinically appropriate.
Can Campral be considered for someone with liver disease?
Campral is not extensively processed by the liver, which may be relevant when alcohol-related liver problems are present. Suitability still requires an individual medical assessment, including kidney function, overall health, and other medicines.
Does Campral affect driving or operating machinery?
Campral is not generally expected to cause marked impairment, but each person’s response can differ. Alcohol withdrawal, poor sleep, dizziness, or concentration difficulties may also affect safety, so avoid driving or hazardous tasks until you know how you feel.
Can Campral affect mood or mental wellbeing?
Recovery from alcohol dependence can involve changes in mood, sleep, anxiety, and stress, whether or not Campral is being used. Campral is not a treatment for depression; new or worsening low mood, agitation, or thoughts of self-harm require prompt clinical help.
What should happen if alcohol use resumes during Campral treatment?
A return to drinking does not automatically mean treatment has failed, but it is important to contact the prescribing clinician or treatment service. They can review safety, withdrawal risk, adherence, and the support plan rather than making changes without medical guidance.
Can Campral be used during pregnancy or while breastfeeding?
The potential benefits and risks should be assessed individually with a clinician because information in pregnancy and breastfeeding is limited. Do not start, stop, or continue Campral in these circumstances without professional advice.
Are regular blood tests needed with Campral?
There is no routine blood test that measures Campral benefit or determines a standard dose. Clinicians may request tests, particularly to assess kidney function or alcohol-related health concerns, based on the individual situation.
Does Campral contain lactose, gluten, or other allergens?
Inactive ingredients can vary between Campral and acamprosate products and may differ by market. Check the supplied patient leaflet and confirm specific allergy or intolerance concerns with a pharmacist before use.
Should Campral be used together with counselling or recovery support?
Campral is usually part of a broader alcohol-dependence care plan rather than a stand-alone solution. Counselling, peer support, relapse-prevention planning, and follow-up can help address the behavioural and social factors involved in maintaining abstinence.
Pharmacist Review
The current Campral product page has been professionally reviewed for clarity, balance and medicine-safety information relevant to patients in Sweden.
| Review detail | Information |
|---|---|
| Reviewed by | Elin Sjöberg, Licensed Pharmacist (Apotekare) |
| Professional identifier | HOSP ID: 5411592 |
| Professional authority | National Board of Health and Welfare (Socialstyrelsen) |
| Review date | 8 March 2025 |
This review considers the page’s presentation of Campral, including appropriate use, precautions and the need to follow prescribing advice. Treatment with acamprosate should be assessed individually by a doctor or other qualified healthcare professional.
Medical disclaimer: This material is provided for informational purposes only and does not replace consultation with a doctor.
Pharmacy location and opening hours
For Campral, visit our pharmacy at Klarabergsgatan 64, 111 81 Stockholm, Stockholm County, Sweden.
| Days | Opening hours |
|---|---|
| Monday–Friday | 07:00–00:00 |
| Saturday | 09:00–22:00 |
| Sunday | 10:00–22:00 |
[…] Campral […]
[…] Campral […]